# Guduchi (à¤—à¥à¤¡à¥‚à¤šà¥€) â€” Giloy

**Sanskrit:** Guduchi (à¤—à¥à¤¡à¥‚à¤šà¥€), Amrita (à¤…à¤®à¥ƒà¤¤à¤¾ â€” "the imperishable/nectar"), Madhuparni, Chinnaruha, Vatsadani
**Common Names:** Giloy, Gurjo (Nepali), Seendal (Tamil), Tippa-teega (Telugu), Amruthaballi (Kannada), Heart-leaved Moonseed
**Botanical:** *Tinospora cordifolia* (Willd.) Miers
**Family:** Menispermaceae
**Part Used:** Stem (primary â€” the woody stem is the classical and pharmacopoeial part), leaves (some formulations), root (limited), starch (Guduchi Satva â€” aqueous extract precipitate)
**Habitat:** Climbing shrub found across tropical India. Grows on Neem, Mango, and other support trees. The host tree may influence chemical profile (Neem-supported Guduchi â€” "Neem Giloy" â€” is traditionally considered superior).

---

## 1. Overview

Guduchi holds a unique dual distinction in Indian healthcare: it is one of Ayurveda's most revered Rasayanas, AND it became one of the most controversial herbs in modern Indian medicine after the COVID-19 pandemic hepatotoxicity reports. Both realities must be addressed honestly.

### Classical References

- **Charaka Samhita** â€” One of the most frequently referenced herbs across all Sthanas. Classified under **Medhya** (intellect-promoting), **Vayahsthapana** (anti-aging), **Deepaniya** (appetite-stimulating), **Triptighna** (thirst-relieving), **Daha Prashamana** (burning sensation-relieving), and **Trishna Nigrahana** (thirst-quenching). Listed as one of the four Medhya Rasayanas (the Guduchi Swarasa form).
- **Sushruta Samhita** â€” Referenced for Jwara (fever), Vatarakta (gout), and Prameha (urinary/metabolic disorders).
- **Ashtanga Hridaya** â€” Described as Tridoshahara (balances all three Doshas) though with primary Pitta and Kapha action.
- **Bhavaprakasha Nighantu** â€” Extensive monograph under Guduchyadi Varga. The name "Amrita" (nectar of immortality) reflects its supreme Rasayana status.

### Classical Indications
- Jwara (Fever â€” especially chronic, recurrent, post-infectious fever. One of the most important Jwarahara herbs)
- Prameha (Metabolic/urinary disorders including Madhumeha â€” diabetes)
- Vatarakta (Gout)
- Kamala (Jaundice â€” historical irony given modern hepatotoxicity reports)
- Pandu (Anaemia)
- Kushtha (Skin conditions)
- Amavata (Rheumatoid arthritis)
- Daha (Burning sensation)
- Krimi (Parasitic conditions)
- Medhya Rasayana (Cognitive rejuvenation)
- Rasayana (General anti-aging)

### The COVID-19 Hepatotoxicity Controversy
In 2020-2022, multiple cases of liver injury (DILI â€” Drug-Induced Liver Injury) were reported in India associated with Giloy consumption. This is addressed in detail in Section 8 (Misuse Patterns). It is the defining safety controversy for this herb in modern Indian medicine.

---

## 2. Ayurvedic Perspective

| Property | Detail |
|----------|--------|
| **Rasa** (Taste) | Tikta (Bitter), Kashaya (Astringent) |
| **Guna** (Qualities) | Laghu (Light), Snigdha (Unctuous) |
| **Virya** (Potency) | Ushna (Heating) |
| **Vipaka** (Post-digestive effect) | Madhura (Sweet) |

### Dosha Action
- **Vata:** Pacifies (Ushna virya + Snigdha guna + Madhura vipaka)
- **Pitta:** Pacifies (Tikta rasa + Madhura vipaka offset the Ushna virya. This is an unusual profile â€” heating virya but still Pitta-pacifying due to predominant Tikta rasa and Madhura vipaka)
- **Kapha:** Pacifies (Tikta rasa + Laghu guna + Ushna virya reduce Kapha)

**Tridoshahara status:** Guduchi is one of the few herbs in Ayurveda genuinely considered Tridoshahara (all three Dosha balancing). This is due to its unique combination: Ushna virya for Vata, Tikta rasa for Pitta and Kapha, Snigdha guna for Vata, Laghu guna for Kapha. However, this does not mean unlimited doses â€” at very high doses, the Ushna virya may aggravate Pitta in sensitive individuals.

### Guduchi Satva
The aqueous starch extracted from Guduchi stems (by soaking, crushing, and precipitating) is called **Guduchi Satva**. It is considered milder, more cooling (Sheeta), and better tolerated than raw stem. Classical texts consider it superior for Pitta conditions and for children. It is also more expensive and frequently adulterated in the market.

---

## 3. Modern Pharmacology

### Key Compounds

- **Tinosporin** â€” Bitter principle. Immunomodulatory.
- **Berberine** â€” Isoquinoline alkaloid. Hepatoprotective, anti-diabetic, anti-inflammatory. Also found in Berberis and Goldenseal.
- **Palmatine** â€” Protoberberine alkaloid. Hepatoprotective, anti-inflammatory.
- **Tinosporaside** â€” Diterpenoid glycoside. Immunomodulatory.
- **Cordifolioside A, B, C** â€” Glycosides. Anti-oxidant, immunomodulatory.
- **Columbin** â€” Diterpenoid. Bitter tonic, anti-pyretic.
- **Tinocordiside** â€” Anti-diabetic activity in animal models.
- **Magnoflorine** â€” Aporphine alkaloid. Anti-inflammatory, immunomodulatory.
- **Polysaccharides (Arabinogalactan)** â€” Major immunomodulatory component. Stimulates macrophage activation.
- **Beta-sitosterol** â€” Phytosterol. Anti-inflammatory.

### The Botanical Identity Problem
A significant concern: *Tinospora crispa* and other Tinospora species are sometimes substituted for *T. cordifolia* in commercial products. Their phytochemical profiles differ. Additionally, the host tree affects Guduchi's chemistry â€” Neem-supported Guduchi may contain absorbed Neem compounds (like azadirachtin metabolites), which alters both efficacy and toxicity profile. Standardisation across products is poor.

### Evidence Table

| Claim | Evidence Level | Notes |
|-------|---------------|-------|
| Immunomodulatory | **B** | Multiple small human trials showing enhanced neutrophil, macrophage, and NK cell activity. Arabinogalactan polysaccharides are well-characterised immune stimulants. However, "immunomodulatory" â‰  "prevents infection" â€” the clinical translation gap applies here as with Tulsi. |
| Anti-pyretic (fever reduction) | **B-C** | Small clinical trials in chronic fevers. Strong traditional use. Animal data robust. Mechanism: anti-inflammatory + immune activation clears infection source. |
| Anti-diabetic (blood sugar) | **B** | Several small RCTs show fasting glucose and HbA1c reduction in type 2 diabetics. Berberine component has independent anti-diabetic evidence. |
| Anti-inflammatory (Rheumatoid arthritis, gout) | **B-C** | Small trials in RA and gout show symptom improvement. Animal data strong (NF-kB inhibition, COX-2 suppression). |
| Hepatoprotective | **C** | Paradox: animal studies consistently show hepatoprotective effects (against CCl4, paracetamol, anti-TB drug toxicity). Yet human case reports show hepatotoxicity. This contradiction is a major unresolved issue (see Section 8). |
| Anti-cancer | **C** | In-vitro anti-proliferative effects (berberine, columbin). No human data. Not a cancer treatment. |
| Cognitive enhancement (Medhya) | **C-D** | Animal studies positive. No human RCTs for cognitive outcomes. Classical Medhya claim without modern validation. |
| Anti-allergic | **C** | Animal and small human studies for allergic rhinitis. Mast cell stabilisation. Promising but insufficient. |
| COVID-19 prevention/treatment | **D** | No evidence that Giloy prevents or treats COVID-19. Promoted during pandemic without clinical trial support. This is addressed in Section 8. |

---

## 4. Safe Usage Ranges (Educational Only)

> **"This is general educational information, not a medical prescription."**

| Form | Typical Adult Range | Notes |
|------|---------------------|-------|
| **Stem powder (Churna)** | 3-6 g/day | Standard form. Bitter taste. |
| **Guduchi Satva** | 500 mg-1 g/day | Aqueous starch extract. Milder. Frequently adulterated with cornstarch/arrowroot in market. |
| **Swarasa (fresh juice)** | 10-20 ml/day | Classical Medhya Rasayana form per Charaka. Requires fresh stems. |
| **Kwath (decoction)** | 50-100 ml/day | Boil 10-15g stem pieces in water, reduce. Traditional fever management. |
| **Standardised extract (tablets/capsules)** | 300-500 mg/day | Commercial form. Standardisation varies. Check berberine/bitter content. |
| **Giloy Ghan Vati** | 1-2 tablets, twice daily | Concentrated aqueous extract tablet. Popular commercial form in India. |

### Duration Considerations
- **Short-term** (1-4 weeks): Well-established for fever management, acute conditions.
- **Medium-term** (1-3 months): Rasayana use, metabolic support.
- **Long-term** (>3 months): **Caution.** Given the hepatotoxicity case reports (see Section 8), continuous use beyond 3 months without liver function monitoring is increasingly difficult to justify from a safety standpoint, regardless of traditional precedent.

### The Freshness Issue
Classical Ayurveda strongly prefers **fresh** Guduchi (Swarasa â€” juice form). Dried stem, tablets, and commercial preparations are processed forms that may lose volatile compounds and alter the chemical profile. Many practitioners believe the hepatotoxicity cases are related to poor-quality, adulterated, or excessively processed commercial products rather than fresh stem preparations. This is plausible but unproven.

---

## 5. Risk Coding

| Condition | Risk Code | Explanation |
|-----------|-----------|-------------|
| **Pregnancy** | ðŸ”´ **Avoid Unless Supervised** | Insufficient safety data. Some animal studies suggest immunostimulatory effects that could affect pregnancy. Classical texts do not prominently recommend it during pregnancy. Default: avoid. |
| **Lactation** | ðŸŸ¡ **Use With Caution** | No safety data. Berberine transfers to breast milk in animal studies. Conservative approach. |
| **Autoimmune disorders** | ðŸ”´ **Avoid Unless Supervised** | Guduchi is one of the strongest immunostimulatory herbs in Ayurveda. In autoimmune conditions (Lupus, RA, MS, Hashimoto's), immune stimulation can worsen the disease. If on immunosuppressants, Guduchi may counteract them. This is not theoretical â€” the immunomodulatory evidence is Level B. |
| **Pre-existing liver disease** | ðŸ”´ **Avoid Unless Supervised** | Given hepatotoxicity case reports (see Section 8), adding any hepatic variable to an already-compromised liver is high-risk. |
| **Liver transplant recipients** | ðŸ”´ **Avoid** | Immunostimulation + hepatic risk + immunosuppressant interference = contraindicated. |
| **Diabetes on medication** | ðŸŸ¡ **Use With Caution** | Additive hypoglycemia with antidiabetic drugs. Berberine has independent glucose-lowering evidence. Monitor. |
| **Blood thinners** | ðŸŸ¡ **Use With Caution** | Limited data, but some anti-platelet activity reported. INR monitoring if on Warfarin. |
| **Children** | ðŸŸ¡ **Use With Caution** | Guduchi Satva is traditionally considered suitable for children at reduced doses. Commercial Giloy tablets: avoid without practitioner guidance. No paediatric safety trials. |
| **Scheduled surgery** | ðŸŸ¡ **Discontinue 2 weeks before** | Immune modulation + blood sugar effects + potential hepatic effects. Standard herbal surgery precaution. |
| **Concurrent hepatotoxic drugs** (Methotrexate, anti-TB drugs, Statins at high doses, Paracetamol overuse) | ðŸ”´ **Avoid Unless Supervised** | Additive hepatic load. If Guduchi has even a small hepatotoxic potential, combining with known hepatotoxins amplifies risk. |

---

## 6. Side Effects

### Common
- Bitter taste / mild nausea (manageable with honey or warm water)
- Mild constipation (some users report this, possibly due to astringent Kashaya rasa)
- Blood sugar reduction (becomes a side effect in diabetics on medication)

### Uncommon
- GI discomfort, bloating
- Headache
- Nasal congestion (immunostimulatory response)

### Rare but Critical
- **Hepatotoxicity (Liver injury)** â€” Multiple case reports in Indian medical literature (2020-2023), including from AIIMS, Chandigarh PGI, and other tertiary centres. Presentations include elevated liver enzymes (ALT, AST), jaundice, and in severe cases, acute liver failure. Cases increased during COVID-19 pandemic megadosing period. Mechanism unclear â€” possibilities include direct toxicity, idiosyncratic reaction, adulterant contamination, or species misidentification. **This is the most serious safety concern for Guduchi in modern practice.** |
- Allergic reaction (rare)
- Hypoglycemia (in diabetics, with concurrent medication)

---

## 7. Drug Interactions

| Drug / Category | Risk | Mechanism |
|----------------|------|-----------|
| **Antidiabetic drugs** | **Moderate** | Additive glucose lowering. Berberine is an independent anti-diabetic agent. |
| **Immunosuppressants** (Cyclosporine, Tacrolimus, Azathioprine, Mycophenolate) | **High** | Guduchi stimulates immune function (Level B evidence). Direct pharmacological opposition to immunosuppressants. Transplant patients: avoid. |
| **Hepatotoxic drugs** (Methotrexate, INH, Rifampicin, high-dose Paracetamol) | **Moderate-High** | Compounded hepatic load given case reports. |
| **Blood thinners** (Warfarin) | **Low-Moderate** | Limited data. Monitor INR. |
| **Sedatives** | **Low** | Minimal sedative interaction expected. |
| **Antihypertensives** | **Low-Moderate** | Some animal data on blood pressure reduction. |
| **Levothyroxine** | **Low** | Theoretical only. Separate intake by 2 hours. |

---

## 8. Misuse Patterns in India â€” The Giloy Hepatotoxicity Crisis

This is the most critical section of this entry.

### What Happened (2020-2022)

During the COVID-19 pandemic:
- The AYUSH Ministry and multiple state governments promoted Giloy as part of "immunity-building" protocols.
- Giloy consumption surged across India â€” as fresh juice (kadha), tablets, commercial products, and in combination with Tulsi, Ashwagandha, and Kalmegh.
- Multiple tertiary hospitals (AIIMS Delhi, PGIMER Chandigarh, KEM Mumbai, CMC Vellore) began reporting cases of **unexplained liver injury** in patients who had been consuming Giloy regularly.
- Case series were published: Devarbhavi et al. (2021) reported Guduchi-associated DILI; multiple authors followed.
- The presentations ranged from asymptomatic liver enzyme elevation to cholestatic jaundice to acute liver failure.

### The Debate

**The hepatology/gastroenterology community** pointed to:
- Temporal correlation (Giloy consumption â†’ liver injury onset, typically 1-3 months)
- Positive dechallenge (liver function improved after stopping Giloy)
- Exclusion of other causes (viral, autoimmune, metabolic, alcohol, other drugs ruled out by RUCAM scoring)
- Multiple independent reports from different centres

**The Ayurveda community** responded:
- Classical texts describe Guduchi as Kamala-hara (jaundice-treating) â€” hepatoprotective, not hepatotoxic
- Animal studies consistently show hepatoprotective effects
- Product quality, adulteration (especially with *Tinospora crispa* or other species), and heavy metal contamination were proposed as the actual cause
- Fresh Guduchi stem used traditionally may be different from commercial dried/extracted products
- Excessive doses during COVID panic (megadosing) are not representative of traditional use

### The Honest Assessment

Both sides have legitimate points. The current evidence suggests:

1. **Guduchi-associated liver injury is real.** The case reports are too numerous, from too many independent centres, with too consistent a clinical pattern to dismiss.
2. **The mechanism is unclear.** It may be idiosyncratic (genetic susceptibility), dose-related (megadosing), product-related (adulteration, contamination, species substitution), or a combination.
3. **Not all Guduchi products are equal.** A fresh stem decoction made at home from verified *T. cordifolia* is pharmacologically different from a commercial tablet of unknown species, standardisation, and quality.
4. **The traditional safety record is not invalidated.** Centuries of use at moderate doses in fresh preparations do constitute a form of long-term observational safety data. But this data did not include pandemic-era megadosing of commercial products.
5. **The responsible position is caution, not denial.** Until the mechanism is clarified: moderate doses, short-to-medium duration, verified quality, liver function monitoring if using >8 weeks, and absolute avoidance in pre-existing liver disease.

### Other Misuse Patterns

**"Immunity booster" daily use:** Same critique as Tulsi. Immunomodulatory â‰  immune boosting. No evidence for infection prevention.

**Combining Giloy + Tulsi + Ashwagandha + Haldi daily:** Polyherbals stacking without constitutional assessment. With Guduchi's hepatotoxicity concern added, the multi-herb daily stack becomes even less defensible.

**Self-medication for fever without diagnosis:** Using Guduchi for fever suppression without establishing the fever's cause can mask serious infections (malaria, typhoid, dengue, TB).

---

## 9. When to See a Doctor

- **Yellowing of skin/eyes, dark urine, pale stools** â€” STOP Guduchi immediately. Seek urgent liver function testing. This is the most critical red flag.
- **Upper right abdominal pain or tenderness** â€” Potential hepatic involvement. Seek care.
- **Persistent nausea, loss of appetite, unusual fatigue** coinciding with Guduchi use â€” Get liver function tests.
- **Hypoglycemia symptoms** while on antidiabetic medication + Guduchi
- **Fever not responding to Guduchi within 3-5 days** â€” The fever's cause needs diagnosis, not more herbs.
- **Autoimmune flare** coinciding with Guduchi use
- **Any unusual symptoms** after starting Guduchi â€” err on the side of caution given the hepatotoxicity controversy

---

## References

- Charaka Samhita â€” Multiple Sthanas (Medhya, Deepaniya, Daha Prashamana, Trishna Nigrahana classifications)
- Bhavaprakasha Nighantu â€” Guduchyadi Varga
- Saha S, Ghosh S. (2012). "Tinospora cordifolia: One plant, many roles." *Anc Sci Life*, 31(4):151-159.
- Sharma V, et al. (2019). "Tinospora cordifolia: Bioactivities and phytochemistry." *Curr Pharmacol Rep*, 5:28-41.
- Devarbhavi H, et al. (2021). "Herbal and dietary supplement-induced liver injury in India." *J Clin Exp Hepatol*, 11(6).
- Zutshi S, et al. (2022). "Tinospora cordifolia-induced liver injury: Emerging concern." *Indian J Gastroenterol*.
- Upadhyay AK, et al. (2010). "Tinospora cordifolia: Pharmacological review." *Int J Pharm Sci Rev Res*, 5(1).
- Sachan S, et al. (2021). "Guduchi hepatotoxicity case series." AIIMS case documentation.

---

*Entry prepared following the Ayurv Educational Framework v2. Last updated: 2026-02-16.*
*This content is for educational purposes only and is not a substitute for professional medical advice. Herbal products can interact with modern medicines and medical conditions.*
